• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idera Pharmaceuticals Inc

+ Add to Watchlist

HXXA:GR

1.913 EUR 0.015 0.78%

As of 02:16:11 ET on 07/11/2014.

Snapshot for Idera Pharmaceuticals Inc (HXXA)

Open: 1.869 Day's Range: 1.869 - 1.914 Volume: 0
Previous Close: 1.928 52wk Range: 0.552 - 5.000 1-Yr Rtn: +230.40%

Stock Chart for HXXA

No chart data available.
  • HXXA:GR 1.913
  • 1D
  • 1M
  • 1Y
1.928
Interactive HXXA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HXXA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3950
Est. PEG Ratio -
Market Cap (M EUR) 157.71
Shares Outstanding (M) 82.44
30 Day Average Volume 163
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HXXA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HXXA

Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

Sudhir D Agrawal "Phil"President/CEOLouis J Arcudi IIISenior VP/CFO/Treasurer/Secy
Louis BrennerSenior VP/Chief Medical OfcrRobert D ArbeitVP:Clinical Development
More Company Profile & Key Executives for HXXA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil